Northwest & Ethical Investments L.P.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 2033536
TORONTO, A6
Position in TEVA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$977,996
+$208,108 QoQ
Shares Held
32,470
+31.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Northwest & Ethical Investments L.P. holds $35,891,165 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
251,525 | $29,732,770 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
5,650 | $3,350,337 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
32,470 | $977,996 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
61,692 | $854,434 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
31,019 | $742,284 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
43,212 | $233,344 |
All Filings in TEVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $977,996 | 32,470 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $769,888 | 24,668 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $716,069 | 35,449 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $663,344 | 39,579 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $548,386 | 35,679 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $312,968 | 14,200 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $180,200 | 10,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $78,000 | 4,800 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||